KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

LIBRETTO-431: Is it time to reconsider randomized phase 3 trials for uncommon oncogenic drivers in non-small-cell lung cancer?

Alessandro Russo, Paola Muscolino, Christian Rolfo

Med 5(2) 112-114

PMID38340705
PMCID-
DOI10.1016/j.medj.2023.12.002
发表日期2024-02-10
摘要

摘要

The recently published results of LIBRETTO-4311 pave the way for a new standard of care in the first-line setting for RET-fusion-positive NSCLCs, which raises important clinical questions not only in the therapeutic landscape of advanced NSCLC but also in the drug development process in the era of uncommon molecular subtypes.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。